STERLING
CELLULAR LONGEVITY LAB
Calibrating cellular systems... 00%
Book Consultation

New York • Zurich

EPIGENETICS & CELLULAR REPROGRAMMING

Recode Aging.
Rewrite Your Biology.

Dr. Evelyn Sterling merges epigenetic reprogramming, advanced autologous therapies, and custom biological algorithms to extend human healthspan at the cellular source.

Initiate Cellular Audit Explore Protocols
BIOLOGICAL CLOCK REALTIME SYNC
-12.4YRS
Median Epigenetic Age Reduction across Phase-III Patients.
MITOCHONDRIAL ATP OPTIMIZED
+42%
Intracellular energy efficiency recovery via co-factor therapies.
CELLULAR HOMEOSTASIS RESTORED
hs-CRP (Inflammation) 0.4 mg/L
Telomere Length 8.4 kb
Sirtuin-1 Activation 3.1x
Scroll to Decelerate Senescence
Dr. Evelyn Sterling in her Zurich Laboratory
15+ Epigenetic Patents
Board Certified Specialist Internal Medicine & Cellular Pathology
THE REVOLUTION

Medicine is no longer reactive.
It is programmatic.

"The traditional paradigm of medicine is designed to manage decay. We do not accept decay. Our mission is to restore cellular intelligence—enabling your body to heal, regenerate, and optimize itself as it did in its biological peak."

Dr. Evelyn Sterling is a pioneer in the field of clinical epigenetics and regenerative therapeutics. Having trained at Harvard Medical School and completed her advanced molecular pathology residency at the Max Planck Institute, she established the Sterling Longevity Lab in New York and Zurich to bring clinical cellular programming out of experimental clinical trials and into highly personalized clinical practice.

01

Harvard & Max Planck

Dual-fellowship specialized in cellular senescence and genetic vector design.

02

Peer-Reviewed Pioneer

Over 40 papers in Nature Medicine and Science on DNA methylation reprogramming.

Dr. Evelyn Sterling, MD, PhD Founder & Clinical Director, Sterling Longevity
THE METHODOLOGY

Cellular Modification Protocols

We deploy targeted biological treatments designed to reprogram your epigenome, clear damaged senescent tissues, and restore youthful cellular communications.

Epigenetic Reprogramming & DNA Methylation

Rewriting environmental genetic switches to download a more youthful transcriptomic expression profile.

Target: Methylation Age Examine Protocol

Stem Cell & Exosome Signatures

Infusing highly localized, tissue-specific autologous stem cells and nano-vesicle messengers to stimulate profound repair pathways.

Target: Tissue Regeneration Examine Protocol

Mitochondrial Optimization & NAD+ Co-Factors

Supercharging intercellular engines with advanced NAD+ precursor molecules and hyperbaric oxygen chambers to restore ATP output.

Target: Cellular ATP Output Examine Protocol

Senolytic Cleansing & Inflammaging Halting

Selective clearing of non-dividing senescent "zombie" cells that spread systemic inflammation to healthy neighboring cells.

Target: Inflammatory hs-CRP Examine Protocol
THE LONGEVITY LAB

Audit Your
Biological Integrity.

Our clinical algorithms estimate your biological cell age divergence by analyzing major physiological pillars.

Use the Interactive Longevity Assessment tool to adjust your biometric data and lifestyle inputs. Our algorithm will immediately calculate your projected Mitochondrial Fatigue Score, Epigenetic Age Gap, and suggest a personalized therapeutic baseline.

🧬
Scientific Accuracy
This tool models clinical clinical markers compiled from over 1,200 clinical study patients undergoing Sterling protocols. It provides a biological estimate, not diagnostic data.
CELLULAR ALGORITHM v4.1
45 yrs
65%
Moderate (7/10)
Average
EPIGENETICAL AGE
43.2
YRS (-1.8 Gaps)
Cellular Rejuvenation Potential High (9.2 yrs)
Primary Structural Pathway Epigenetic Methylation Modulators
Secure your cellular baseline. This diagnostic report can be directly transmitted to our Swiss medical lab before your call.
Transmit Report & Book consultation
CLINICAL VALIDATION

Biomarker Journeys

We measure biological metrics in cold data. View raw, quantified scientific results achieved across our core longitudinal studies.

12-MONTH INTERVENTION

Subject 402: 54-Year-Old Biotech Executive

The subject presented with advanced systemic oxidative stress, elevated arterial plaque markers, and a chronological-biological age divergence of +4.2 years (methylated cellular aging older than chronological age).

Intervention: Dual autologous stem cell infusions targeted at coronary/vascular pathways paired with targeted daily Yamanaka methylation factor support and mitochondrial photobiomodulation.

-8.4 yrs Methylation Cell Age Gap
-64% C-Reactive Protein (CRP)
+24% Cardiovascular VO2 Max

Biomarker Optimisation Path

58.2 54.0 49.8 Age Baseline Month 3 Month 6 Month 12 Chronological Age (54) 58.2 45.6
Epigenetic Cell Age Chronological Age Reference
6-MONTH INTERVENTION

Subject 118: 41-Year-Old Athletic Male

The subject presented with persistent tendon inflammation and significant cellular senescence, experiencing sluggish physical recovery metrics post ultra-marathon performance.

Intervention: Targeted Senolytic chemical infusions to purge metabolic "zombie cells" coupled with systemic hyperbaric oxygen protocols and exogenous NAD+ cellular resuscitation.

-4.9 yrs Methylation Cell Age Gap
-81% Senescent Cell Biomarkers
+39% Mitochondrial ATP Efficiency

Senescent Cell Biomarker Clearance

100% 50% 19% Beta-Gal Baseline Month 1.5 Month 3 Month 6 100% 19%
Beta-Galactosidase (Senescence Marker)
18-MONTH INTERVENTION

Subject 309: 67-Year-Old Female Philanthropist

Subject presented with advanced bone density loss, high levels of systemic inflammation (hs-CRP), cognitive fatigue symptoms, and immunological degradation.

Intervention: Monthly therapeutic cellular plasma exchanges to dilute systemic senescent secretions, coupled with bone-marrow-derived signaling factor infusions and high-performance neural peptides.

-11.2 yrs Methylation Cell Age Gap
+44% Bone Osteoblast Activity
+52% T-Cell Immunological Index

Immunological Age Restoration

70.0 64.0 58.0 Imm-Age Baseline Month 6 Month 12 Month 18 69.5 54.3
Immunological Lymphocyte Health Assessment
THE SANCTUARY

Where Medical Rigor Meets
Uncompromising Serenity.

Healing cannot happen in clinical hostility. We have reimagined the clinical environment to serve as a calming extension of our molecular therapeutics.

Nestled along Zurich's pristine Bahnhofstrasse and Manhattan’s quiet, elegant Upper East Side, our clinics are designed with high-end, clean architectural details. Incorporating air filtration and custom light configurations designed to match your body’s natural biological rhythm, we ensure that every second spent under our care activates parasympathetic nervous systems and biological restoration.

📍 ZURICH CLINIC

Bahnhofstrasse 104, 8001 Zürich, Switzerland

Active Labs • Dynamic Hyperbarics
📍 NEW YORK CLINIC

710 Park Ave, New York, NY 10021, USA

Autologous Synthesis • Cryo-Suites
Sterling Longevity Clinic Zurich Suite
100% ISO Class-5 Cleanrooms
24h Private Concierge Support
THE INSIGHTS

The Longevity Journal

Explore clinical insights and medical commentary co-authored by Dr. Sterling, breaking down cellular pathways and emerging longevity literature.

EPIGENETICS JULY 2026

Yamanaka Transcriptional Factors: Safely Recoding Somatic Cells In Vivo

An in-depth evaluation of chemical genetic agents designed to trigger systemic transcriptional reprogramming without causing tissue tumor risks.

Read Investigation
METABOLICS JUNE 2026

Mitochondrial Collapse: The Primary Biochemical Driver of Human Fatigue

Analyzing chronological decay pathways within mitochondrial membranes, and how targeted NAD+ co-factor delivery halts age-related cell death.

Read Investigation
SENOLYTICS MAY 2026

Target Clearance: Identifying and Eliminating Senescent Secretory Phenotypes

Evaluating compound efficiency in isolating biological senescence and preventing cells from releasing chronic inflammatory proteins.

Read Investigation
CONSULTATION

Initiate Your
Biological Transformation.

We do not treat symptoms. We reprogram systems. All relationships with our clinic begin with an intensive molecular cellular audit.

Please submit your basic medical profile below. Our admissions board will evaluate your candidate profile. If accepted, you will receive an invitation to our physical clinic in Zurich or New York for dynamic genome profiling and blood paneling.

ZURICH CLINIC

Next Diagnostic Intake: August 17, 2026

Limit: 4 patients remaining in cycle.

NEW YORK CLINIC

Next Diagnostic Intake: August 22, 2026

Limit: 2 patients remaining in cycle.

01. Patient Credentials

02. Bio-Profile Overview

🧬

Transmission Complete

Your candidate profile has been securely encrypted and submitted directly to Dr. Evelyn Sterling's clinical admissions team in Zurich.

Status Pending Medical Board Screening Est. Response Time Within 36-48 Clinical Hours